tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TGTX Stock Latest News

Buy Rating Backed by Briumvi’s Strong Commercial Ramp, Growing CD20 Market Share, and Visible Long‑Term Revenue Expansion
RatingsBuy Rating Backed by Briumvi’s Strong Commercial Ramp, Growing CD20 Market Share, and Visible Long‑Term Revenue Expansion
2d ago
TGTX
TG Therapeutics sees FY26 revenue $875M-$900M, consensus $897.64M
PremiumThe Fly
TG Therapeutics sees FY26 revenue $875M-$900M, consensus $897.64M
2d ago
TGTX
TG Therapeutics reports Q4 EPS 14c, consensus 33c
PremiumThe Fly
TG Therapeutics reports Q4 EPS 14c, consensus 33c
2d ago
TGTX
TG Therapeutics expects cash to fund business based on current operating plan
PremiumThe Fly
TG Therapeutics expects cash to fund business based on current operating plan
2d ago
TGTX
TGTX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TGTX Upcoming Earnings Report: What to Expect?
4d ago
TGTX
TG Therapeutics announces long-term data on Briumvi published in JAMA Neurology
PremiumThe FlyTG Therapeutics announces long-term data on Briumvi published in JAMA Neurology
11d ago
TGTX
TG Therapeutics price target lowered to $46 from $49 at JPMorgan
Premium
The Fly
TG Therapeutics price target lowered to $46 from $49 at JPMorgan
26d ago
TGTX
Buy Rating on Briumvi Driven by Strong Commercial Momentum, 2026 Growth Outlook, and Underappreciated Autoimmune Pipeline Optionality
Premium
Ratings
Buy Rating on Briumvi Driven by Strong Commercial Momentum, 2026 Growth Outlook, and Underappreciated Autoimmune Pipeline Optionality
1M ago
TGTX
TG Therapeutics price target raised to $39 from $37 at Goldman Sachs
PremiumThe Fly
TG Therapeutics price target raised to $39 from $37 at Goldman Sachs
1M ago
TGTX
Midday Fly By: Big banks report mixed quarterly results
PremiumThe Fly
Midday Fly By: Big banks report mixed quarterly results
1M ago
KO
BLK
TG Therapeutics rises 12.2%
PremiumThe Fly
TG Therapeutics rises 12.2%
1M ago
TGTX
Unusually active option classes on open January 14th
PremiumThe Fly
Unusually active option classes on open January 14th
1M ago
BAC
DVN
Video: Wells Fargo dips as big bank earnings continue
PremiumThe FlyVideo: Wells Fargo dips as big bank earnings continue
1M ago
WFC
FTNT
Closing Bell Movers: Glaukos slips 13% after pre-announcement
Premium
The Fly
Closing Bell Movers: Glaukos slips 13% after pre-announcement
2M ago
SPT
BBCP
TG Therapeutics Announces Strong 2025 BRIUMVI Revenue Outlook
Premium
Company Announcements
TG Therapeutics Announces Strong 2025 BRIUMVI Revenue Outlook
2M ago
8K
TGTX
TG Therapeutics reports preliminary Q4 revenue $182M, consensus $182.38M
PremiumThe Fly
TG Therapeutics reports preliminary Q4 revenue $182M, consensus $182.38M
2M ago
TGTX
TG Therapeutics sees FY26 revenue $875M-$900M, consensus $895.63M
PremiumThe Fly
TG Therapeutics sees FY26 revenue $875M-$900M, consensus $895.63M
2M ago
TGTX
TG Therapeutics price target raised to $15 from $13 at BofA
PremiumThe Fly
TG Therapeutics price target raised to $15 from $13 at BofA
2M ago
TGTX
TG Therapeutics Earnings Call: Strong Growth and Positive Outlook
PremiumCompany Announcements
TG Therapeutics Earnings Call: Strong Growth and Positive Outlook
4M ago
TGTX
TG Therapeutics Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsTG Therapeutics Reports Strong Q3 2025 Results
4M ago
TGTX
Positive Outlook for TG Therapeutics Driven by Strong Financial Performance and Strategic Initiatives
Premium
Ratings
Positive Outlook for TG Therapeutics Driven by Strong Financial Performance and Strategic Initiatives
4M ago
TGTX
Positive Outlook on TG Therapeutics: Strong Revenue Growth and International Expansion Drive Buy Rating
Premium
Ratings
Positive Outlook on TG Therapeutics: Strong Revenue Growth and International Expansion Drive Buy Rating
4M ago
TGTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >